Sabra Healthcare REIT, Inc. $SBRA Shares Purchased by Barclays PLC

Barclays PLC increased its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 116.2% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,426,718 shares of the real estate investment trust’s stock after purchasing an additional 766,740 shares during the quarter. Barclays PLC owned 0.57% of Sabra Healthcare REIT worth $26,594,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of SBRA. Cornerstone Wealth Management LLC increased its holdings in Sabra Healthcare REIT by 256.6% in the third quarter. Cornerstone Wealth Management LLC now owns 39,781 shares of the real estate investment trust’s stock valued at $742,000 after buying an additional 28,625 shares during the last quarter. AlphaQuest LLC lifted its holdings in Sabra Healthcare REIT by 309.2% during the 3rd quarter. AlphaQuest LLC now owns 144,839 shares of the real estate investment trust’s stock worth $2,700,000 after buying an additional 109,444 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al grew its position in shares of Sabra Healthcare REIT by 51.2% in the 3rd quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 577,800 shares of the real estate investment trust’s stock worth $10,770,000 after acquiring an additional 195,600 shares in the last quarter. Franklin Resources Inc. raised its position in shares of Sabra Healthcare REIT by 27.4% during the 2nd quarter. Franklin Resources Inc. now owns 503,499 shares of the real estate investment trust’s stock valued at $9,285,000 after acquiring an additional 108,268 shares in the last quarter. Finally, Allianz Asset Management GmbH raised its position in shares of Sabra Healthcare REIT by 9.9% during the 3rd quarter. Allianz Asset Management GmbH now owns 902,998 shares of the real estate investment trust’s stock valued at $16,832,000 after acquiring an additional 81,293 shares in the last quarter. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Trading Down 0.8%

Shares of SBRA opened at $20.65 on Thursday. The company has a current ratio of 4.29, a quick ratio of 4.29 and a debt-to-equity ratio of 0.90. Sabra Healthcare REIT, Inc. has a 1-year low of $15.75 and a 1-year high of $21.07. The stock has a market capitalization of $5.21 billion, a P/E ratio of 32.27, a P/E/G ratio of 1.67 and a beta of 0.64. The business’s 50-day moving average price is $19.58 and its 200 day moving average price is $18.99.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.26). The firm had revenue of $201.35 million for the quarter, compared to analyst estimates of $201.97 million. Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. Sabra Healthcare REIT’s revenue for the quarter was up 16.2% compared to the same quarter last year. During the same period last year, the firm earned $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, February 27th. Stockholders of record on Friday, February 13th were paid a dividend of $0.30 per share. The ex-dividend date was Friday, February 13th. This represents a $1.20 annualized dividend and a dividend yield of 5.8%. Sabra Healthcare REIT’s dividend payout ratio is 187.50%.

Analyst Ratings Changes

A number of equities analysts have commented on the company. Scotiabank lifted their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “sector perform” rating in a research note on Monday, March 2nd. Cantor Fitzgerald raised their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research note on Tuesday, February 17th. Citizens Jmp boosted their price target on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a report on Wednesday, February 18th. Weiss Ratings restated a “buy (b)” rating on shares of Sabra Healthcare REIT in a research report on Thursday, January 22nd. Finally, UBS Group lifted their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a report on Thursday, February 19th. Five analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $21.80.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.